News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
891,522 Results
Type
Article (89329)
Company Profile (562)
Press Release (801603)
Multimedia
Podcasts (266)
Webinars (42)
Section
Business (267292)
Career Advice (4173)
Deals (40091)
Drug Delivery (211)
Drug Development (91965)
Employer Resources (210)
FDA (18687)
Job Trends (17530)
News (399289)
Policy (40036)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (5)
2027 Genetown Standard (10)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
Academia (3089)
Academic (2)
Accelerated approval (68)
ADA (51)
Adcomms (44)
Allergies (221)
Alliances (56994)
ALS (262)
Alzheimer's disease (2087)
Antibody-drug conjugate (ADC) (666)
Approvals (19169)
Artificial intelligence (1034)
ASCO (345)
Autoimmune disease (436)
Automation (74)
Bankruptcy (412)
Belgium (7)
Best Places to Work (12635)
BIO (81)
Biologics (15)
BIOSECURE Act (23)
Biosimilars (282)
BioSpace Insights (252)
Biotechnology (340)
Bispecific (3)
Bladder cancer (230)
Brain cancer (95)
Breast cancer (913)
Cancer (7315)
Cardiovascular disease (634)
Career advice (3620)
Career pathing (61)
CAR-T (422)
CDC (78)
CDMO (180)
Celiac Disease (4)
Cell therapy (1169)
Cervical cancer (61)
Clinical research (80118)
Collaboration (2666)
Commercialization (13)
Company closure (10)
Compensation (1780)
Complete response letters (123)
COVID-19 (3062)
CRISPR (139)
C-suite (1571)
Cystic fibrosis (178)
Data (9722)
Decentralized trials (3)
Denatured (104)
Depression (219)
Dermatology (132)
Diabetes (769)
Diagnostics (7810)
Digital health (80)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (520)
Drug pricing (252)
Drug shortages (39)
Duchenne muscular dystrophy (363)
Earnings (103696)
Editorial (84)
Employer branding (26)
Employer resources (180)
Events (140123)
Executive appointments (1322)
Eye disease (1)
FDA (23380)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (25)
Frontotemporal dementia (39)
Funding (2195)
Gene editing (299)
Generative AI (105)
Gene therapy (925)
GLP-1 (1339)
Government (5605)
Grass and pollen (8)
Guidances (436)
Healthcare (21391)
Hematology (198)
HIV (116)
Huntington's disease (77)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (134)
Immunology and inflammation (403)
Immuno-oncology (140)
Indications (249)
Infectious disease (3493)
Inflammatory bowel disease (253)
Inflation Reduction Act (17)
Influenza (160)
Intellectual property (363)
Interviews (826)
IPO (18045)
IRA (61)
Job creations (5211)
Job search strategy (2879)
JPM (73)
Kidney cancer (28)
Labor market (137)
Layoffs (713)
Leadership (60)
Legal (10176)
Licensing (29)
Liver cancer (115)
Longevity (46)
Lung cancer (1002)
Lymphoma (521)
Machine learning (76)
Management (70)
Manufacturing (1478)
Marketing (14)
MASH (240)
Medical affairs (3)
Medical device (15414)
Medtech (15683)
Mergers & acquisitions (23513)
Metabolic disorders (1983)
mRNA (308)
Multiple sclerosis (227)
Multispecific (1)
NASH (24)
Netherlands (6)
Neurodegenerative disease (583)
Neuropsychiatric disorders (147)
Neuroscience (4083)
Neurotech (2)
NextGen: Class of 2026 (7718)
Non-profit (5162)
Now hiring (93)
Obesity (935)
Opinion (397)
Ovarian cancer (264)
Pain (320)
Pancreatic cancer (405)
Parkinson's disease (458)
Partnered (48)
Patents (760)
Patient advocacy (1)
Patient recruitment (952)
Patient selection (3)
Peanut (74)
People (68716)
Peptides (7)
Pharmaceutical (83)
Pharmacy benefit managers (40)
Phase 1 (24726)
Phase 2 (34761)
Phase 3 (26205)
Pipeline (12308)
Policy (417)
Postmarket research (3561)
Preclinical (11063)
Press Release (72)
Prostate cancer (379)
Psychedelics (92)
Radiopharmaceuticals (414)
Rare diseases (1482)
Real estate (7473)
Recruiting (83)
Regenerative medicine (3)
Regulatory (31334)
Reports (93)
Research institute (2803)
Resumes & cover letters (656)
Rett syndrome (52)
RNA editing (33)
RSV (102)
Schizophrenia (210)
Series A (377)
Series B (269)
Service/supplier (16)
Sickle cell disease (138)
Special edition (35)
Spinal muscular atrophy (197)
Sponsored (58)
Startups (4390)
State (2)
Stomach cancer (22)
Supply chain (159)
Tariffs (105)
The Weekly (159)
Vaccines (1390)
Venture capital (163)
Weight loss (632)
Wet AMD (1)
Women's health (168)
Worklife (27)
Date
Last 7 days (577)
Last 30 days (2434)
Last 365 days (33423)
2026 (24149)
2025 (33213)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1302)
Alabama (112)
Alaska (7)
Arizona (457)
Arkansas (16)
Asia (52817)
Australia (9296)
California (15945)
Canada (4454)
China (1849)
Colorado (680)
Connecticut (712)
Delaware (493)
Europe (121851)
Florida (2427)
Georgia (522)
Hawaii (5)
Idaho (70)
Illinois (1384)
India (132)
Indiana (723)
Iowa (31)
Japan (706)
Kansas (153)
Kentucky (66)
Louisiana (68)
Maine (95)
Maryland (1913)
Massachusetts (11601)
Michigan (456)
Minnesota (880)
Mississippi (7)
Missouri (180)
Montana (37)
Nebraska (31)
Nevada (177)
New Hampshire (92)
New Jersey (4194)
New Mexico (38)
New York (4177)
North Carolina (2104)
North Dakota (12)
Northern California (8052)
Ohio (511)
Oklahoma (31)
Oregon (49)
Pennsylvania (3060)
Puerto Rico (34)
Rhode Island (57)
South America (1672)
South Carolina (97)
South Dakota (2)
Southern California (6324)
Tennessee (267)
Texas (2616)
United States (56745)
Utah (483)
Vermont (2)
Virginia (404)
Washington D.C. (88)
Washington State (1290)
West Virginia (4)
Wisconsin (179)
Wyoming (4)
891,522 Results for "molmed s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AINN-P1: Small Model, Big Intelligence
AINN-P1: Small Model, Big IntelligenceHow does a 167M-parameter protein foundation model outperform a 650M general-purpose model on the tasks that matter?
September 10, 2026
·
1 min read
Press Releases
Agilent to Participate in J.P. Morgan U.S. All Stars Conference 2026
September 11, 2026
·
1 min read
Press Releases
Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference
September 13, 2026
·
1 min read
Press Releases
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 18, 2026
·
1 min read
Press Releases
Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase
May 18, 2026
·
5 min read
Press Releases
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 20, 2026
·
1 min read
Press Releases
ChemoMetec A/S invites to conference call on September 11, 2026 at 3:00 p.m. CEST on its upcoming 2025/26 Annual Report
August 9, 2026
·
1 min read
Press Releases
Reviva to Participate in Fireside Chat at A.G.P.’s Annual Healthcare Company Showcase
May 18, 2026
·
1 min read
Cystic fibrosis
Sionna’s cystic fibrosis failure is a windfall for Vertex’s blockbuster franchise
A surprise flop in Phase 2a cystic fibrosis trial sent Sionna’s shares plummeting, but for Vertex, the news reinforced its standard-of-care standing with highly successful drugs like Trikafta.
August 10, 2026
·
2 min read
·
Michael Gibney
FDA
Amylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, more
Amylyx shares good news for its investigational GLP-1 blocker; Definium announces positive data for its LSD-based therapy in anxiety; Summit/Akeso’s ivonescimab shows degrading survival benefits; patients treated with Neurocrine’s Prader-Willi drug experience serious adverse events; and Eli Lilly cracks down on the black market for next-gen obesity asset retatrutide.
August 19, 2026
·
2 min read
·
Jef Akst
1 of 89,153
Next
